Nature Reviews Drug Discovery

Source: Wikipedia, the free encyclopedia.
Nature Reviews Drug Discovery
DisciplinePharmacology, Biotechnology
LanguageEnglish
Edited byPeter Kirkpatrick
Publication details
History2002–present
Publisher
FrequencyMonthly
120.1 (2022)
Standard abbreviations
ISO 4Nat. Rev. Drug Discov.
Indexing
CODENNRDDAG
ISSN1474-1776 (print)
1474-1784 (web)
LCCN2002243044
OCLC no.427380493
Links

Nature Reviews Drug Discovery is a monthly peer-reviewed review journal published by Nature Portfolio. It was established in 2002[1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick.[2] According to the Journal Citation Reports, the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology"[3] and 1st out of 279 journals in the category "Pharmacology & Pharmacy".[4]

Reviews are commissioned to specialists and supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal publishes analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.[5]

See also

References

  1. ^ "Displaying Record for Publication: Nature Reviews Drug Discovery". CASSI. Chemical Abstracts Service. Retrieved 2022-08-09.
  2. ^ "About the Editors". nature.com. Springer Nature. Retrieved 2022-08-09.
  3. ^ "Journals Ranked by Impact: Biotechnology & Applied Microbiology". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.
  4. ^ "Journals Ranked by Impact: Pharmacology & Pharmacy". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.
  5. ^ Guide : Information : Nature Reviews Drug Discovery. Nature.com. Retrieved on 2011-06-29.

External links